Researchers Develop Promising Hantavirus Treatments Amid Funding Challenges
Researchers in Chile, Argentina, and the United States are making progress in developing treatments and vaccines for hantavirus, a rare but deadly virus transmitted by rodents. Despite the virus being known for decades, limited funding has hindered the development of effective treatments. Recent outbreaks, such as one on a cruise ship, have highlighted the need for medical solutions. A study published recently suggests that a drug used for autoimmune diseases may help mitigate severe symptoms of hantavirus. The Andes virus, a strain capable of human-to-human transmission, is a particular focus due to its high mortality rate. Efforts are also underway to develop vaccines and antibody treatments, although these face significant financial and logistical hurdles. 
